Company News

CIR Director Andersen To Be Honored by FDLI

Food and Drug Law Institute recognizes service, leadership.

Author Image

By: TOM BRANNA

Editor

When the Food and Drug Law Institute (FDLI) presents its Distinguished Service and Leadership Award tomorrow at The Westin Georgetown in Washington, DC, F. Alan Andersen director, Cosmetic Ingredient Review (CIR), will be among the four recipients.



Andersen is also president of the FDA Alumni Association.


The awards recognize individuals from various areas of the food and drug law community for their notable service and leadership.


Prior to joining CIR in 1993, Anderson worked for 22 years in FDA’s radiological health/medical devices area, conducting research and later directing the device standards program, the research and testing laboratories and the device evaluation office. He has chaired the ANSI Medical Device Standards Board, and is past president of the clinical lab standards group. At FDA, he received the PHS Superior Service Award, the FDA Award of Merit, an Employees EEO Recognition Award, and has since received the FDA Distinguished Alumni Award and has been made a Penn State Alumni Fellow. Dr. Anderson received his BS from Muhlenberg College and his MS and PhD from Penn State.

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. FDLI’s scope includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.


Also to be presented with honors are Deborah M. Autor, deputy commissioner for Global Regulatory Operations and Policy, Food and Drug Administration; Robert P. Brady, Partner, Hogan Lovells; and Eugene M. Thirolf, Jr., a consultant.

Keep Up With Our Content. Subscribe To Happi Newsletters